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The human pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the major pandem-
ic of the twenty-first century. We analyzed more than 4700 SARS-CoV-2 genomes and associated metadata retrieved from
public repositories. SARS-CoV-2 sequences have a high sequence identity (>99.9%), which drops to >96%when compared
to bat coronavirus genome. We built a mutation-annotated reference SARS-CoV-2 phylogeny with two main macro-hap-
logroups, A and B, both of Asian origin, and more than 160 sub-branches representing virus strains of variable geographical
origins worldwide, revealing a rather uniform mutation occurrence along branches that could have implications for diag-
nostics and the design of future vaccines. Identification of the root of SARS-CoV-2 genomes is not without problems, owing
to conflicting interpretations derived from either using the bat coronavirus genomes as an outgroup or relying on the sam-
pling chronology of the SARS-CoV-2 genomes and TMRCA estimates; however, the overall scenario favors haplogroup A
as the ancestral node. Phylogenetic analysis indicates a TMRCA for SARS-CoV-2 genomes dating to November 12, 2019,
thus matching epidemiological records. Sub-haplogroup A2 most likely originated in Europe from an Asian ancestor
and gave rise to subclade A2a, which represents the major non-Asian outbreak, especially in Africa and Europe.
Multiple founder effect episodes, most likely associated with super-spreader hosts, might explain COVID-19 pandemic to
a large extent.
[Supplemental material is available for this article.]
The human severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) was first detected in late 2019 in patients from the
city of Wuhan (Hubei province, China) suffering from respiratory
illnesses and leading to a disease that has been popularized as co-
ronavirus disease or COVID-19. The disease was declared an
International Public Health Emergency on January 30, 2020, and
a few weeks later, on March 11, 2020, it was declared a pandemic
by the World Health Organization (WHO 2020). Even though it
has not been possible to trace an index case, there is a large amount
of epidemiological information that has been very useful for track-
ing the pandemic spread of SARS-CoV-2. The first report of
COVID-19 took place on December 1, 2019, in a patient from
Wuhan, most likely linked to the city’s Huanan Seafood
Wholesale market. Some public reports indicated that the first
COVID-19 patients could date back to mid-November 2019. The
number of cases grew gradually during December, and most of
them were related to the aforementioned seafood market. In
mid-January 2020, a number of patients appeared in other prov-
inces of China, probably fostered by the large annual human mi-
gration associated to the Spring Festival travel season (starting in
mid-December and lasting for about 40 days). Soon COVID-19
spread to other Asian countries (South Korea, February 20, 2020),
and beyond: Middle East (Iran; February 19, 2020), the United
States (February 20, 2020), Europe (Italy and Spain, January 31,
2020), and so forth.
Wu et al. (2020) reported the first genome sequence of SARS-
CoV-2 (29,903 bp length) from a worker at the Wuhan market ad-
mitted to the Central Hospital of Wuhan on December 26, 2019;
this patient experienced severe respiratory syndrome. The investi-
gators identified a new RNA virus strain belonging to the family
Coronaviridae that was subsequently designated as “WH-Hum 1
coronavirus” (and also “2019-nCoV”). According to Coutard
et al. (2020), the nearest bat precursor would be RaTG13 with a ge-
nome identity to SARS-CoV-2 of 98%. Phylogenetic studies sup-
ported the theory of a natural origin for SARS-CoV-2 (Andersen
et al. 2020).
Since the beginning of the COVID-19 pandemic, there has
been a growing interest in exploring SARS-CoV-2 genetic variation
tohelp to understand the origin and spread of the pandemic and to
facilitate the development of future vaccines and diagnostics. The
amount of genome data deposited in public repositories in such a
reduced time frame offers a unique opportunity to carry out a de-
tailed phylogenetical characterization of SARS-CoV-2 genomes,
as well as a geographic mapping of the different clades spreading
worldwide, and to study impact of the outbreaks on the genome
variability of the virus. Initial analyses so far used a limited number
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of SARS-CoV-2 genomes and focusedmostly on various evolution-
ary aspects of the coronavirus genomes (Andersen et al. 2020; For-
ster et al. 2020; Li et al. 2020; Shen et al. 2020). The Global
Initiative on Sharing Avian Influenza Data (GISAID) (Shu and
McCauley 2017) provides public access to the most complete col-
lection of genetic sequences of several viruses, with special empha-
sis on influenza viruses. In 2020, GISAID started to compile
sequence data from the virus causingCOVID-19, and now itmakes
thousands of genomic sequences of the virus available. The China
National Center for Bioinformation keeps an updated resource
on COVID-19 (https://bigd.big.ac.cn/ncov/tool/annotation?lang=
en) (Zhao et al. 2020) and provides different analytical tools to
study SARS-CoV-2 variation. The open-source project Nextstrain
(https://nextstrain.org) (Hadfield et al. 2018) provides an interac-
tive web portal that allows navigating SARS-CoV-2 genome varia-
tion and helps tracking the spread of disease outbreaks.
In the present study, we built a solid phylogenetic skeleton of
SARS-CoV-2 genomes that allows us to investigate sequence varia-
tion in a large number of genomes (more than 4700) deposited in
GISAID, explore site-specific mutational instability, investigate
different scenarios for the root of SARS-CoV-2 genomes, analyze
phylogeographic patterns of variation worldwide, and investigate
transmission patterns of the disease, for example, the impact
of homogeneous versus super-spreader transmissions in the
pandemic.
Results
Identity of SARS-CoV-2 to other closely related species
Human SARS-CoV-2 genomes have a within sequence identity of
99.98% (Table 1) and aremuchmore identical to bat coronaviruses
than to pangolin coronaviruses, although the values vary substan-
tially depending on the specimen (93.44%–96.17%) (Table 1).
When compared to pangolin coronaviruses, the range of genome
identities drops to 85.24%–92.35%.
Between 1699 and 3727 substitution variants separate the
pangolin coronavirus genomes from the SARS-CoV-2 reference se-
quence, and this range drops to 1105–1369 (Table 1) when com-
pared to bat coronavirus genomes. The bat #412976 is
problematic because it has an unusual number of mutational dif-
ferences with respect to the SARS-CoV-2 reference and has an ab-
normal low sequence identity with human coronaviruses
(76.87%), comparable to pangolin coronaviruses. Therefore, this
genome complicates sequence alignment and should be avoided
in future comparative analyses.
Interspecific phylogeny and problematic inference of the root of
SARS-CoV-2
An interspecific maximum likelihood (ML) tree was built using
pangolin, SARS-CoV-1, and bat coronavirus genomes as outgroups
to investigate their phylogenetic relationships with SARS-CoV-2
(Supplemental Fig. S1). The tree depicts the SARS-CoV-1 genome
in the most external branch. Next, all the pangolin genomes clus-
ter separately from bat and human coronaviruses, which also
group separately. In line with its very low identity with SARS-
CoV-2, bat #412976 behaves as an outlier in the tree. Overall,
the clustering pattern in the phylogeny is in very good agreement
with sequence identity values (Table 1).
We next focused our attention on the root for all existing
SARS-CoV-2 genomes, assuming themost related bat and pangolin
coronavirus genomesas the closest coronavirus relatives.Webuilt a
new ML tree including most related bat and pangolin coronavirus
sequences as outgroups and all SARS-CoV-2 genomes sequenced
up to February 29, 2020 (n =621); almost all of themare of Asianor-
igin and this group of sequences should contain the most recent
common ancestor (MRCA), because it is evident from phyloge-
netics and epidemiology that the origin of the pandemic is in
China (see below and Supplemental Material). The ML tree reveals
that the root of SARS-CoV-2 is located in B1 (Fig. 1A). In agreement
with the ML tree, the bat genomes share the variants that
Table 1. Interspecific comparisons of sequence identities between different coronaviruses, including those from pangolin (Manis javanica) and
bat (Rhinolophus affinis) against the whole HQ SARS-CoV-2 data set (3478 genomes)
Species ID Place Year DIF ID (%) SD Max (%) Min (%) 8782 18060 28144 29095
SARS-CoV-1 GB: NC_004718.3 Toronto; Canada 2004 4576 79.26 0.05 79.67 78.64 C T T T
Pangolin GS: 410544 Guangdong; China 2019 1699 92.35 0.03 92.51 91.47 T A C T
Pangolin GS: 410721 Guangdong; China 2020 2599 90.21 0.03 90.44 89.56 T A C T
Pangolin GS: 412860 China 2019 2320 90.12 0.03 90.39 89.63 T A C T
Pangolin GS: 410539 Guangxi; China 2017 3720 85.35 0.04 85.59 84.74 T T C T
Pangolin GS: 410538 Guangxi; China 2017 3720 85.36 0.03 85.59 84.46 T T C T
Pangolin GS: 410543 Guangxi; China 2017 3495 85.24 0.04 85.47 84.55 T T N T
Pangolin GS: 410542 Guangxi; China 2017 3727 85.34 0.04 85.58 84.71 T T C T
Pangolin GS: 410541 Guangxi; China 2017 3721 85.35 0.04 85.58 84.72 T T C T
Pangolin GS: 410540 Guangxi; China 2017 3716 85.36 0.04 85.60 84.74 T T C T
Bat GS: 402131 Yunnan; China 2013 1105 96.17 0.02 96.37 95.53 T T C T
Bat GS: 412977 Yunnan; China 2019 1369 93.44 0.04 93.75 92.80 T T C T
Bat GS: 412976 Yunnan; China 2019 3827 76.87 0.05 77.31 76.69 C C A –
Canine GS: 414518 Hong Kong 2020 11 99.95 0.07 99.99 96.15 C C T C
Tiger GS: 420293 New York; USA 2020 7 99.97 0.07 100.00 96.17 C C T C
Human GB: MN908947.3 Shanghai; China 2020 0 99.98 0.07 100.00 96.18 C C T C
(Year) Collection year of the specimen; (DIF) number of mutational differences of the coronavirus genomes compared to the SARS-CoV-2 reference se-
quence (MN908947.3); (ID) average identity of the HQ SARS-CoV-2 genomes against the corresponding coronavirus genomes in the table; (SD) stan-
dard deviation of DIF values; (Max and Min) maximum and minimum identities shown by a SARS-CoV-2 genome with the other coronaviruses.
ID refers to identity number in GISAID (GS; omitting the prefix “EPI-ISL-”) and GenBank (GB). NC_004718.3 corresponds to the reference SARS-CoV-1
Coronavirus genome (Marra et al. 2003). The genome #402131 corresponds to RaTG13, which has been used in the literature as bat coronavirus refer-
ence. GISAID 414518 and 420293 correspond to coronaviruses analyzed from a dog and a tiger (Panthera tigris jacksoni) that were infected by human
SARS-CoV-2.
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characterize haplogroup B1 and separate them from A (C8782T,
C18060T, and T28144C) (Table 1). However, if we restrict the anal-
ysis to genomes appearing beforemid-January, we observe that the
root of SARS-CoV-2 appears inhaplogroupB2 (this is becauseB1ge-
nomes disappear from the data set) (Supplemental Fig. S2). The bat
genome share also the diagnostic variant that leads from B to B2
(C29095T) (Table 1). In agreement with this observation, the net-
work provided by Forster et al. (2020) (their Fig. 5) indicates that
the root of SARS-CoV-2 is located in a reticulation that we could
identify as being representative of either haplogroups B1 or B2.
SARS-CoV-2 weighted mean substitution rate, as inferred
from the ML tree, is 5.42 ×10−4 substitutions per site per year (s/
s/y) (Bootstrap 2.5%–97.5%CI: 4.29×10−4 to 8.02×10−4 s/s/y) ac-
cording to an uncorrelated relaxed-clockmethod; a slightly higher
mutation rate of 6.05×10−4 s/s/y (Bootstrap 2.5%–97.5% CI: 4.46
×10−4 to 8.22× 10−4 s/s/y) was obtained assuming a strict-clock
model. According to a relaxed-clock model mutation rate, the
time of the most recent common ancestor (TMRCA) for all SARS-
CoV-2 genomes dates to November 12, 2019 (Bootstrap 2.5%–
97.5%CI: August 7, 2019 toDecember 8, 2019), fullymatching ep-
idemiological dates (considering an incubation period of about 2
wk before the first COVID-19 case reported on December 1,
2019) (Huang et al. 2020); estimates using a strict-clock mutation
rate varied very little: November 7, 2019 (Bootstrap 2.5%–97.5%
CI: August 18, 2019 to December 2, 2019).
Inference of the root based on ML and using an outgroup ap-
pears however to be in full conflict with the chronology of the
SARS-CoV-2 genomes and the evolutionary pattern suggested by
this chronology in its initial Asian outbreak. The first genomes se-
quenced were sampled from initial COVID-19 cases in Hubei,
China. Thereby, the first genome (December 24, 2019) corre-
sponds to a member of haplogroup A, whereas the first B genome
(a basal B haplotypes) appears nearly 2 wk later (January 5, 2020),
when A had already accumulated 23 genomes in the database and
substantial genomevariability (Fig. 1B). HaplogroupB increased its
frequency progressively in the next few weeks after its first
B
A
Figure 1. Contrasting evidence supporting different roots for SARS-CoV-2 genomes. (A) Interspecific ML tree using genomes sampled in GISAID before
March 2020, indicating the root in haplogroup B1 for all existing SARS-CoV-2 genomes. (B, left) The histograms on the right represent the number of unique
haplotypes belonging to haplogroups A and B accumulated during the first 6 wk of the pandemic, whereas the histograms on the left show the evolution of
the frequencies of haplogroups A and B in the same period (note that A and B frequencies are complementary); (middle) growth of sample size of themain A
branch (red solid line) and A sub-branches (red dashed lines) and the main B branch (green solid line) and B sub-branches (green dashed lines), indicating
that B and derivative clades appear at a later moment of the pandemic than A and its subclades. The gray vertical line separates year 2019 from year 2020;
(right) boxplot and density function of the life-span period of identical haplotypes in the database (as a proxy for the life-span period of a SARS-CoV-2 ge-
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appearance in the database, and new subclades of A and B ap-
peared almost at the same time around both main branches (Fig.
1B). Although B2 emerged in the database on January 10, 2020
in the Chinese province of Guangdong (quite far away from
Hubei), B1 emerged even later in Hubei, on January 19, almost at
the same time as A3 (nearly a month after haplogroup A) and
about a week before A2 (February 28). Taking all this timing
scheme into account and considering a TMRCA of SARS-CoV-2 ge-
nomes of November 12, the most logical progression of the evolu-
tionary events would be A>B>B1. The inverted progression B1>B
>A (as suggested by ML analysis) would be very difficult to recon-
cile with the chronology of the genomes if we take into account
the following three considerations: (1) the average life span of a
SARS-CoV-2 genomeworldwide (estimated by looking at the chro-
nology of identical haplotypes) is about 7 d, with amaximum (bar-
ring exceptional values) of about 23 d (median=3.0; whisker
upper limit = 23.5; these values are very homogeneous when esti-
mated from different representative countries) (Fig. 1B); (2) the vi-
rus mutates slightly faster than 1 or 2 mutations every month
(Kupferschmidt 2020); and (3) there are three mutational steps
separating A from B1. Therefore, a scenario for B1 to be in the
root, bearing in mind the incubation period and that the first
member of A appeared on December 24, 2019, would require
that B1 existed from the very beginning (∼November 12), that is,
about >60 d before A. If that was the case, it is difficult to explain
(1) why B1 remained unsampled for >3 mo until the end of
January, and (2) the unusually long life span for the B1 lineage
(∼3 mo for the basal B1 haplotype) (Fig. 2A,B).
With the aim of further exploring the root of all present-day
SARS-CoV-2 genomes, we computed the TMRCA for both lineages
using A and B haplotypes sampled in China until the end of
February. TMRCA for haplogroup A (n=176) is December 2, 2019
(Bootstrap 2.5%–97.5% CI: October 7, 2019, to December 12,
2019), whereas for haplogroup B (n=92) it is >2 wk more recent,
namely, December 20, 2019 (Bootstrap 2.5%–97.5% CI: October
10, 2019, toDecember 29, 2019). Althoughwith lower sample sizes
(and therefore very largeCI),we alsoobtainedconsistentlymore re-
cent TMRCAs for B1 (n =6; 23 December 2019; Bootstrap 2.5%–
97.5% CI: May 24, 2019, to January 18, 2020) and B2 (n=13;
January 3, 2020; Bootstrap 2.5%–97.5% CI: August 18, 2019, to
January 9, 2020). The more recent TMRCAs for B, B1, and B2
than for A are consistent with the fact that the B, B1, and B2 haplo-
types sampled on January 4, 10, and 22, 2020, correspond to the
basal nodes (they carry only the mutations that characterize their
sequence motifs), with no variation accumulated that could indi-
cate an older age for these haplogroups.
Intraspecific phylogeny and phylogeographic patterns of SARS-
CoV-2
Themost parsimonious tree (Fig. 3) shows that, in agreement with
previous investigators (including Nextstrain) (Tang et al. 2020),
B
A
Figure 2. Scheme explaining two alternative models for the location of the root of the SARS-CoV-2 genomes according to their chronologies. (A)
Locating the root in haplogroup A would be consistent with a logical evolutionary time line that accounts for the number of mutations accumulated
from an alleged pre-A ancestor originating from a zoonotic transmission between an intermediary animal and humans (occurring ∼November 12,
2019) and also consistent with TMRCA values estimated for Chinese A, B, B1, and B2 haplotypes (see text). The alternative of considering B1 as the
root would enter into conflict (represented by a question mark) with mutation rates of SARS-CoV-2 genomes, coupled with the large unsampled period
needed to explain the hypothetical first appearance of B1 on approximately November 12, 2019 and its first sampling on January 19, 2020, as well as
TMRCA for haplogroups A, B, B1, and B2 (see text). (B) The scheme summarizes the two alternative evolutionary scenarios assuming roots in haplogroup
A or B1, according to the time lines outlined in the upper panel.
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the two very stable transitions C8782T and T28144C (3 and 1 total
occurrences in the global phylogeny, respectively) separate SARS-
CoV-2 variation into two main clades, A and B, both originating
in China. In addition to these well-known main nodes, we identi-
fied 164 haplogroups (Fig. 3; for mutational pathways to phyloge-
netic branches, see Supplemental Table S2). The structure of the
branches in the parsimonious tree fully agrees with the skeleton
shown in the ML tree (Supplemental Material; Supplemental Fig.
S3) and the MDS analysis that clusters genomes according to diag-
nostic variants (Supplemental Fig. S4).
Sub-haplogroups emerging from these main clades are main-
ly supported by single mutations, most of them beingmutational-
ly very solid along the phylogeny (Supplemental Material;
Supplemental Table S1; Supplemental Fig. S5), therefore granting
the robustness of the different clades. Mutations distribute along
the whole extension of the coronavirus genome in a rather uni-
form way (Supplemental Fig. S6).
Supplemental Figure S7 describes the accumulation of ge-
nomes in GISAID partitioned by main haplogroups, indicating
the importance of A and sublineages of A in the pandemic (see be-
low); whereas Supplemental Figure S8 shows the frequency of
these main lineages per continental region and also diversity val-
ues, showing substantially heterogeneous patterns worldwide
(Supplemental Table S3).
Phylogeographic information allows reconstructing dynam-
ics of (sub)haplogroups worldwide (Fig. 4). The two main clades
(A and B) and most of their main first step–derived subclades
(e.g., A1, A3, B1, B2) originated in Asia (mostly in China), but nu-
merous subclades (some of them reaching locally high frequen-
cies) most likely appeared outside Asia; most of these subclades
emerged by the occurrence of domestic mutations that accumulat-
ed on top of Asian and non-Asian ancestor clades (next section;
Supplemental Material).
Haplogroup A, with complementary frequencies to B, is the
predominant clade across the world (n=2715, 80% of all the
high-quality [HQ] database) (Fig. 4), although with patterned dis-
tributions geographically (see frequency interpolated maps in
Supplemental Fig. S9). The core haplotype of A is the reference
Figure 3. Maximum parsimony tree of SARS-CoV-2 genomes. Small histograms represent relative frequencies of the given haplogroup or sub-hap-
logroup in the different regions.Mutations along branches are referred to changes against the reference sequence.Mutations in dark green indicate parallel
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SARS-CoV-2 genome for nomenclature, and it is themost frequent
one within paraphyletic A (A∗) and one of the most frequent with-
in the whole haplogroup A; this haplotype was almost exclusively
sampled in Asia (56 of 70 genomes in the database). Haplogroup A
reaches its highest frequencies in Europe (97%) and Africa (93%),
but it is also very frequent in Asia and Oceania (77% in both con-
tinents), whereas it has the lowest frequencies in South America
(68%) and North America (53%). A2 is, by far, the most frequent
subclade of haplogroup A worldwide, and the vast majority of
the available A2 genomes belong to its subclade A2a (n=1814;
68% of all A genomes; substitutions C241T–C3037T–A23403G
from A to A2, and C14408T from A2 to A2a), this subclade is the
main representative of the non-Asian outbreak, followed by A1a
(n=287; 11%) (Supplemental Fig. S9). According to the genome
chronology, the first A2 genome available in Europe corresponds
to a Bavarian (German) patient (GISAID: #406862) and was sam-
pled on January 28, 2020; this genome contains nomutational dif-
ferenceswith respect to the root of A2 (Fig. 3). The next A2 genome
sequence was sampled in a Chinese patient from Shanghai
(GISAID: #416334) on February 6, 2020, but this Asian genomedif-
fers by two substitutions with respect to the root, suggesting that is
a derived genome imported to China fromEurope. The next A2 ge-
nomes appeared in the Belgium and US data sets. The chronology
of genomes supports therefore a European origin for A2 (Fig. 4). In
agreement, the first two A2a genomes appear in Europe too. In par-
ticular, these two genomes occur in one of the main initial foci for
the European outbreak, namely Lombardy in Italy, on February 20
and 24, 2020; soon after, two other A2a representatives appeared
in Madrid and Castilla-Leon (Spain) on February 24 and 25,
2020, respectively. A2a is mostly present in Europe (n=1184;
77% of all genomes in Europe and 65% of all A2a sequences world-
wide), and it probably originated from a European A2 genome
(most likely from Italy) (Fig. 4). In agreement with a non-Asian or-
igin of A2a, the database registers the first East Asian basal A2a ge-
nomes onMarch 11, 2020. Therefore, phylogeographic inferences
point to a European origin for both A2
and its highly successful subclade A2a.
Haplogroup A3 is the most common A
sub-haplogroup in Asia (24% of its ge-
nomes), and it most likely originated
there, in particular in China, where it
appears from January 18, 2020
(Supplemental Fig. S9). Different sub-
clades of A2a spread most successfully
in some continents, for example,
A2a4 (with the diagnostic MNP
GGG28881AAG on top of A2a motif) in
South America (41% of all A sequences
vs. 0% A2a2a) and A2a2a (substitution
C1059T on top of A2a2) in North
America (61% of all A sequences vs. 8%
of A2a2a), but both subclades probably
originated in Europe (A2a2a most likely
in France). A2a4 is one of the most wide-
spread subclades; it reaches the highest
European frequency in Switzerland
(53% of all lineages in this country) and
the Netherlands (51%); the first genome
in the database was sampled in Italy on
February 25, 2020. Other minor clades
were detected in very restricted geograph-
ic areas; for instance, A4a is exclusively
found in Wales (United Kingdom) (39 of 76 [51%] genomes in
this region) (Supplemental Fig. S9), whereas, for example, minor
clades A5, A7, and A9b appear only in the Asian data set.
Haplogroup B (n=652; 20% of the genomes in the database)
is present in all continents, with higher prevalence in North
America (47%), South America (32%), and Asia and Oceania
(23%) (Supplemental Fig. S9). Haplogroup B1, separated from B
by a single transition (C18060T), is by far the largest B subclade
(n=424; 64% of all B). The main proportion of B1 lineages world-
wide is in the subclade B1a1 (A17858G andC17747T substitutions
on top of B1), which shows the highest frequency in North
America (n=357; 42% of all the genomes in the region and 55%
of all existing B genomes worldwide) (Supplemental Fig. S9).
B1a1 splits into 10 minor subclades (from B1a1a to B1a1j) (Fig.
3), each defined by characteristic single mutations; most of them
(if not all) probably originated in North America.
Asia is the only region containing genomes belonging to all
first level and minor B-subclades (B1, B2, B3, etc; perhaps with
the exception of the minor clade B9 which could have originated
in Spain). The first three basal B1 haplotypes appeared inChina on
February 19 and 21, and the next one in the United States on
February 25; then a few more appeared only in China and other
Asian locations. The overall chronology and its phylogenetic fea-
tures therefore suggest China as the most likely origin for B1.
There are several subclades within the B phylogeny that originated
in non-Asian regions. For instance, in Europe, themain B subclade
is B3a (70% of all B haplotypes in Europe; B >B3: diagnostic vari-
ants T9477A–C14805T–C28863T, and B3>B3a: substitutions
G25979T–C28657T), which emerged at the end of February 2020
in Europe (as did its immediate ancestor B3), and it is particularly
prevalent in Spain, one of the main European epicenters of
COVID-19 (Supplemental Fig. S9). It is most likely that most of
these B3a representatives arrived in South America (where it repre-
sents 71%of all the B genomes) fromSpain given the high connec-
tivity between the two regions (Fig. 4). Moreover, the high B3
Figure 4. Map showing the worldwide spread of the main SARS-CoV-2 clades. Circle areas are propor-
tional to frequencies (e.g., A2a is contained within A, and so on), and the arrows indicate just an approx-
imate reconstruction of the phylodynamics of SARS-CoV-2 from the beginning of the Asian outbreak to
the non-Asian spread of the pathogen based on the phylogeny, genome chronology (as recorded in the
metadata that indicates the sampling origin and dates), and genome variation. Classification of genomes
into haplogroups is according to the phylogeny shown in Figure 3. Minor subclades are indicated in rec-
tangular shapes with their corresponding labels. In addition, other minor haplogroups involved in the
SARS-CoV-2 spread (in brackets are the number of subclades involved) are indicated below continental
labels.
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frequency observed in Spain marks a notable difference with re-
spect to other European countries: 32 of the 37 (86%) B3 genomes
in Europe are found in Spain. Conversely, B4a1 probably originat-
ed inNorth America inMarch 2020, evolving from anAsian B4a (B
>B4: variant G28878A; B4>B4a: variant G29742A, and B4a>
B4a1: transversion A22606T).
The number of sequences belonging to clade A and its main
subclades increased exponentially during the outbreak occurring
outside Asia at the end of February 2020, while the frequency of
haplogroup B genomes increased more slowly during that time
(Supplemental Material; Supplemental Fig. S10). Nucleotide diver-
sity is almost homogeneous across all the different geographical re-
gions for the main haplogroups; however, haplotype diversity
(HD) values varymore substantially among haplogroups, probably
indicating the weight of sequence founders in this statistical index
(see next section on super-spreaders) (Supplemental Material).
Super-spreaders and founder effects
A fewhaplotypes are disproportionally represented in specific con-
tinental regions or countries (Supplemental Material;
Supplemental Fig. S11), appearing abruptly in a period of a few
days. This pattern might be compatible with super-spreaders act-
ing on certain geographic locations and giving rise to severe foun-
der effects. Haplotypes H1, H2, H3, and H4 (IDs as in
Supplemental Table S4) are the most frequently repeated ones.
Haplotype H1 (n=133; root haplotype of A2a2a: C1059T–
C14408T–A23403G–C241T–G25563T–C3037T) occurs in Europe
at high frequency (75/133; 56%) and in North America (48/133
[36%]; mostly in the United States with 45 occurrences); the first
instances appeared in France on February 21 and 28, 2020. H2 (n
=132; root haplotype of B1a1: C17747T–A17858G–C18060T–
T28144C–C8782T) appears at high frequency and almost exclu-
sively in the United States (126/132; 95%); the initial instances
emerged in the United States from February 20, 2020, onward.
H3 (n=94; the root haplotype of A2a4: C14408T–A23403G–
C241T–GGG28881AAC–C3037T) reaches very high frequency in
the United Kingdom (26/94; 28%) and Australia (11/94; 12%);
this haplotype is the most widespread one in the global database
(being present in 16 countries across all continents). Haplotype
H4 (n=78; haplogroup A) corresponds to the reference sequence
(GenBank accession number MN908947.3) and it reaches the
highest frequency in Asia (61/78; 78%), particularly in China
(53/78; 68%); the frequency of H4 increased in two pulses, one co-
inciding with its first appearance in China at the end of December
2019, and the next coinciding with the large Asian outbreak in
mid-February 2020; later, H4moved to other non-Asian locations,
for example, the United States (11/78; 14%). Several other highly
frequent haplotypes emerged during the pandemic worldwide,
many of them deriving from clade A2a (e.g., H6 [n=55; hap-
logroup A2a4a; first instance in Italy]; H7 [n=38; haplogroup
A2a3; first instances in France and Switzerland]) (Supplemental
Table S4).
There are additional examples of SARS-CoV-2 high-frequency
haplotypes (Supplemental Table S4) appearing in very restricted
geographic areas. For instance, H9 (n=33; haplogroup A3) appears
at high frequency in Japan (28/33; 85%, and 29%of all genomes in
Japan). In Iceland, founder haplotypes represent a large propor-
tion of all existing haplotypes on the island, for example, H8 (hap-
logroup A2a5a) exists only in Iceland (n=37; 14% of all genomes
in Iceland), and together with H1 (n=15 in Iceland) and other
three haplotypes, sumup 53%of all the haplotypes in this country
(77 of the total 144; 53%). In theUnited States, H1 occurs 45 times,
and H2 126 times; together with six other haplotypes, they make
up 32%of all genomes in this country (241 of the total 756). In the
United Kingdom, haplotype H3, together with eight other haplo-
types, make up 28% of the total haplotypes (112 of the total 393).
H10 (n=26; B3a) and H15 (n =22; A2a5) are among the main hap-
lotypes responsible for the initial Spanish outbreak; H10 (21/26 in
Spain; 81%) is particularly interesting because it belongs to hap-
logroup B3a, whereas almost all European haplotypes belong to
haplogroup A (Supplemental Material).
Common haplotypes are frequently shared between neigh-
boring countries, an observation mirroring the easy spread of the
virus over short geographic distances: for instance, H33 (n=9; of
which seven are in Portugal and two in Spain) or H46 (n=7; of
which four are in Portugal and one in Spain).
We further explored the phylogenies of these high-frequency
haplotypes to gain insight into transmission patterns (Fig. 5); in
particular,wewere interested in exploring if these patterns are con-
sistent with the figure of super-spreader hosts. Table 2 shows nor-
malized phylogenetic tree features for a selected number of super-
spreader candidates. For each geographic region, we additionally
obtained index values for the rest of the tree excluding these can-
didates. The phylogenetic trees have expected values compatible
with super-spreader transmissions and less compatible with ho-
mogeneous and chains of transmissions (overall if considering
the phylogenies coupled with the moderate mutation rate of
Table 2. Normalized phylogenetic features of super-spreader candidates in specific regions
Clade n n1 n2 AL CH CI IL PF SC SN
Iceland: A2a2a 54 34 20 0.288 0.148 0.866 0.885 0.111 0.881 0.925
Iceland minus A2a5a/A1a1/A1a2/A2a4a3a/A2a2a 117 — — 0.024 0.592 0.143 0.415 0.408 0.207 0.685
Japan: A3 69 28 41 0.137 0.174 0.728 0.851 0.174 0.757 0.912
Japan minus A3 28 — — 0.115 0.571 0.194 0.462 0.429 0.410 0.704
Washington: B1a1 268 94 174 0.038 0.231 0.641 0.774 0.179 0.650 0.880
Washington minus B1a1 37 — — 0.067 0.433 0.389 0.586 0.250 0.466 0.763
Spain: B3a 31 21 10 0.897 0.129 0.933 0.931 0.097 0.945 0.933
Spain minus B3a/A2a5 20 — — 0.167 0.400 0.175 0.667 0.600 0.469 0.737
Wales: A4a1 21 18 3 1.000 0.095 1.000 1.000 0.143 1.000 0.950
Wales: A4a 18 13 5 1.000 0.111 1.000 1.000 0.167 1.000 0.941
Wales minus A4a1/A4a 39 — — 0.063 0.615 0.164 0.405 0.538 0.345 0.605
Diamond Princess cruise ship 25 8 17 0.283 0.400 0.728 0.652 0.120 0.793 0.791
(n) Total sample size; (n1) sample size of the principal node (only for super-spreader candidate); (n2) sample size of derived haplotypes (only for super-
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SARS-CoV-2 and the mean incubation period of COVID-19). For
instance, clade A2a2a in Iceland has a Colless’s index of 0.866,
but this value is only 0.143 when excluding candidate super-
spreaders nodes. The IL number (A2a2a: 0.885 vs. Remaining
Tree (RT): 0.415), the Sacking index (A2a2a: 0.881 vs. RT: 0.207),
and the staircase-ness (A2a2a: 0.925 vs. RT: 0.685) are also consis-
tently high as expected from super-spreader transmissions. Also
consistent with this super-spreader model of transmission are
the low values observed for the cherries (A2a2a: 0.148 vs. RT:
0.592) and pitchforks (A2a2a: 0.111 vs. RT: 0.408). The rest of
the super-spreader networks in Supplemental Table S4 follow sim-
ilar patterns.
Networks of super-spreader candidates (Fig. 5) show a starlike
shape, which is characteristic of super-spreader transmission
(Colijn and Gardy 2014) and clearly differs from other patterns
in the general tree that are more characteristic of homogeneous
or chain transmissions. The most outstanding super-spreader
event occurred inWashington state (Fig. 5). This network involved
about 328 genomes, and its shape suggests that a single super-
spreader (carrying a coronavirus belonging to B1a1 lineage) could
have driven an important proportion of coronavirus transmissions
involved in the basal node. However, the data available in the pre-
sent study cannot conclusively identify if the sequences depicted
in the network and representing an important proportion of a sin-
gle subclade were the result of one or a few super-spreaders; such
level of detail might only be determined using epidemiological
and clinical data (see Discussion).
Values for the Diamond Princess cruise ship are also compara-
ble to those obtained for the super-spreader candidates (Table 2;
Supplemental Material; Supplemental Fig. S12).
Evolution of effective population size of SARS-CoV-2
Extended Bayesian skyline plot (EBSP) analysis undertaken on ge-
nomes sampled until the end of February (Supplemental Material)
reflects with great precision the main COVID-19 epidemiological
episodes. If we consider the estimated TMRCA for SARS-CoV-2 to
November 12, 2019, and allowing 14–24 d of disease incubation
(until approximately December 6), this leaves a period of 2 or 3
wk of silent local transmission of the virus until the first case is re-
ported in Wuhan on December 30, 2019. From this moment, Ne
begins to increase slightly for a couple of weeks (Fig. 6B), followed
by exponential growth from January 20, 2020, coincidingwith the
Asian outbreak. The peak is reached on January 30, matching the
Asian lockdown. Consequently, Ne drops for the next couple of
weeks, but starts to grow progressively again from February 12, co-
inciding with the beginning of the non-Asian outbreak.
By overlaying COVID-19 incidence (officially reported cases
per day worldwide; https://ourworldindata.org) to the EBSP plot,
we observed comparable shape distributions, but with a 14–15 d
delay in reported cases per day worldwide relative to the EBSP dis-
tribution (Fig. 6B).
Association of SARS-CoV-2 lineages with sex and age
Age and sex distribution vary among countries sampled
(Supplemental Fig. S13). Several statistical tests were carried out
to explore the possible association between coronavirus strains,
age, and sex. After correcting formultiple tests, we did not find sol-
id evidence indicating significant associations between these two
variables and the SARS-CoV-2 main clades (Supplemental
Material; Supplemental Table S5).
Figure 5. Network analysis of main super-spreader candidates (see also
Supplemental Data; Supplemental Table S4) in various geographic re-
gions. A network was first computed for all the haplotypes in the region,
and a zoomed network was built for the main super-spreader candidates.
Areas of the circles are proportional to the number of haplotypes. In the
case of B1a1 representation (Washington state; USA), only derived haplo-
types from the core with one or two mutations are represented in the left
subgraph. Heptagons in branches indicate the number of mutations in the
corresponding branch.
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Discussion
We undertook a large-scale analysis of SARS-CoV-2 genomes con-
sidering a sample size that is more than an order of magnitude
higher than those of previous studies. By focusing on high-quality
(HQ) genomes, we devoted great effort to elucidate the most parsi-
monious phylogeny of SARS-CoV-2. Thus, we present novel phy-
logeographic inferences on the origin and dynamics of SARS-
CoV-2 strains. In particular, we discussed the conflicting evidence
on the origin of SARS-CoV-2 and discovered a few dozen genomes
(representing more than one-third of the total database) that
played a fundamental role in the spread of COVID-19. These
SARS-CoV-2 strains (belonging to different haplogroups) occurred
with high frequency in the data set in short time periods (of a few
days) and became founders in restricted regions or countries (Fig.
6A); the phylogenic characteristics of these haplotypes are compat-
ible with the existence of super-spreaders playing an important
role in the propagation of the COVID-19 pandemic.
A practical application of the SARS-CoV-2 tree built in the pre-
sent study is to facilitate classification of genomes into clades,
which might facilitate the work of epidemiologists and other spe-
cialists seeking potential correlations between clade members and
the different clinical phenotypes observed in COVID-19, disease
severity, and differential spread of the diseaseworldwide. The phy-
logeny presented is scalable, and nomenclature works in a hierar-
chical way similar to that shown to be successful in other research
areas such as human population genetics (e.g., mtDNA studies). In
addition, we consider that a stable nomenclature is needed to facil-
itate future comparisons. For instance, Nextstrain has recently
changed the nomenclature of main branches, while haplogroups
A and B in Forster et al. (2020) are inverted with respect to A and
B in the previous version of Nextstrain (and here); overall, these
different nomenclatures (and others used in preprints) add to
the confusion when comparing different studies.
SARS-CoV-2 genomes show very high identity among them-
selves (>99%) and lower to bat coronaviruses (>96%; BatCoV
RaTG13); these values are very similar to earlier estimates based
on a limited number of SARS-CoV-2 genomes (Ceraolo and
Giorgi 2020; Coutard et al. 2020; Lam et al. 2020; Tang et al.
2020). The pangolin coronavirus genome, initially proposed as
the original host of SARS-CoV-2, shows significantly lower identi-
ty. The high identity observed between SARS-CoV-2 genomes and
other betacoronaviruses adds support to its zoonotic origin from a
bat relative (Ceraolo and Giorgi 2020). The differences found be-
tween SARS-CoV-2 and their most closely related coronaviruses
in horseshoe bat indicate that a large number of mutational jumps
was needed to generate these differences from a common ancestor
that could have existed in a time frame between 1948 and 1982
(Boni et al. 2020). Divergent genomes could have been incubated
in animal reservoirs before the occurrence of the zoonotic jump to
humans in the shape of an A or a B genome, in a process similar to
that observed for palm civet as intermediary in other SARS
BA
C
Figure 6. Phylogenetic and phylodynamics of SARS-CoV-2, and timeline of the pandemic. (A) Simplified SARS-CoV-2 phylogeny (schematic version of
Fig. 3) illustrating the main worldwide branches and the haplogroups responsible for the main outbreaks (founders favored by super-spreading) occurring
in Asia and outside Asia (colored filled circles). The overall distribution color keys refer only to pie charts, and the main founder color keys refer only to filled
circles. (B) EBSP based on genomes sampled from the beginning of the pandemic until the end of February 2020 (n=621). The orange distribution shows
the real number of cases per day as recorded in https://ourworldindata.org for the same time period (we disregarded the abnormal peak occurring on
February 13, 2020, because more than 15,000 new cases were reported in China in just 1 d, most likely representing unconfirmed cases). (C) Time line
of the main events occurring during the pandemic, and indicating the MRCA of all SARS-CoV-2 genomes; the dotted area is a schematic representation
of the real diversity values reported in Supplemental Figure S10 and Supplemental Table S3. Divergence dates between SARS-CoV-2 and bat sarbecoro-
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coronaviruses (Hu et al. 2017). These new coronaviruses would be
able to use human ACE2 receptor to infect patient cells. Patterns of
variation observed in SARS-CoV-2 could be explained assuming a
unique index case, which would already contain the very specific
andwell-conserved 12nt polybasic furin cleavage site (PFCS) inser-
tion. This original SARS-CoV-2 genomewould then start to diverge
very soon inWuhan in two directions of the phylogeny, giving rise
to the two main branches: haplogroup A had more success in the
non-Asian pandemic, whereas haplogroup B achieved only local
success in some particular regions outside Asian (e.g., sublineage
B1a1 in the United States, or B3a in Spain) (Fig. 6C, time line).
In selecting a root for the phylogeny, we prioritized A (genome
chronology and phylogeographic criteria) over B1 (ML trees). For
B1 (or B2 or even B) to be the real root for the SARS-CoV-2, we
would need to assume an exceptionally large period for B genomes
remaining unsampled, which is incompatible with the mutation
rates and life span of coronavirus strains (Fig. 2B). A root in hap-
logroup A would also be supported by a more recent TMRCA
(December 2, 2019, compared to December 20, 2020 for hap-
logroup B).
According to our inferences, the TMRCA for all SARS-CoV-2
genomes would be November 12, 2019. Assuming a maximum in-
cubation time in humans of up to 24 d (Guan et al. 2020), the virus
could have been infecting the first citizens from Hubei in a silent
mode of transmission until the end of November 2019 and started
to be noticed by Chinese health authorities in early to mid-
December. The EBSP distribution suggests that the effective popu-
lation size (Ne) of SARS-CoV-2 started to grow significantly from
December 30, 2019, that is, only 2–3 wk after the initial cases
were reported, andwas probably favored by super-spreaders; for ex-
ample, genomes like the reference sequence (H4) (Supplemental
Table S4) played a special role in the beginning of the Asiatic epi-
demic. Subsequently, it followed an exponential growth that
marked the beginning of the Asian outbreak on January 20,
2020, and lasted until the end of January. Next, Ne experienced a
notable drop coincidingwith human intervention and quarantine
implemented in Asia on January 30, 2020. Finally, the beginning
of a second wave of expansion outside Asia starting around
February 12–27, 2020, is also well-recorded on the SARS-CoV-2 ge-
nomes (Fig. 6B).
The 2-wk delay between the dates suggested by the EBSP dis-
tribution and the official documented incidence of COVID-19 in
Asia could be attributable to (1) an underestimate obtained by
the EBSP analysis, (2) the mean incubation time of the disease,
and/or (3) the number of cases officially declared in this period be-
ing below the real incidence of the disease.
Phylogeographic analysis of SARS-CoV-2 genomes allowed us
to investigate pandemic dynamics worldwide.Members belonging
to clade A were probably among the first ones to leave Asia before
this region established a severe population lockdown; and the sub-
clade named A2a, most likely emerging in Europe, gave rise to one
of the most successful strains worldwide (it represents 55% of the
global database). There is strong evidence pointing to the role of
important founder events in the pandemic occurring inmany con-
tinental regions and restricted locations, especially outside China.
Phylogeographic analysis of SARS-CoV-2 genomes also enables us
to identify a number of super-spreader candidates (n=49)
(Supplemental Table S4), which might explain the multiple foun-
der events observed worldwide; one of these super-spreading
events could have been responsible for the origin and success of
A2a. In Iceland, Gudbjartsson et al. (2020) recently showed a con-
tact tracking network (their Fig. 4B) that could represent one of the
many super-spreading events that existed in Iceland and that is in-
directly observed in our analyses based on genomes. These founder
haplotypes have four differential features: (1) they reached high to
moderate frequencies, (2) they are characteristic of specific conti-
nental regions or even individual countries, (3) they appeared in
a very short time period of only a few days, and (4) the variation
emerging from the core haplotypes (Fig. 5; Table 2) has to a great
extent the signature expected from super-spreaders. Therefore, al-
though these analyses do not allow investigating individual trans-
missions, overall, they allow identifying a phylogenetic pattern
that is compatible with super-spreaders and that differs from the
signal generated by transmission chains and homogeneous trans-
missions. The data suggest that these genomes could have played a
fundamental role in COVID-19 spreading for the period represent-
ed in the database; they alone represent 34% of the total genomes
in the database, but their impact could be higher if we consider all
the derived haplotypes emerging from each founder. This finding
is in good agreement with recent results from epidemiological
studies and observations as well as mathematical simulations
(Endo et al. 2020; Kupferschmidt 2020) indicating important indi-
vidual-level transmission in COVID-19, with dispersion parameter
k estimated to be around 0.1. Moreover, the role of super-spreaders
is well reported in previous pandemics, including SARS,MERS, and
Ebola (Stein 2011; Wong et al. 2015).
With the data available in GISAID, we were not able to detect
association betweenmain haplogroups and age and sex. However,
further research is needed to investigate the possible differential ef-
fect of strains (haplogroups) with the disease outcome and biolog-
ical traits.
Evidence of natural selection acting on SARS-CoV-2 genomes
needs further investigation (Supplemental Material), although the
data suggest purifying selection acting onmost of the SARS-CoV-2
genes when explored at an interspecific level, andweaker intraspe-
cific purifying selection. In agreement with this latter observation
is the recent report indicating an 81-nt deletion at geneORF7a that
would convert the coronaviruses into a less virulent pathogenwith
reduced short-term selective advantage (Holland et al. 2020).
However, none of the HQ genomes investigated in our report carry
this deletion.
We found the PFCS in all SARS-CoV-2 genomeswith only two
exceptions (belonging to different haplogroups) (Supplemental
Material). This segment is therefore highly mutationally stable. A
BLAST search (https://blast.ncbi.nlm.nih.gov/) of the PFCS indi-
cates that this sequence segment is specific to SARS-CoV-2. The
fact that the PFCS has been found universally in all SARS-CoV-2
suggests that this insertion was acquired before the zoonotic event
(and is therefore present in the root, i.e., pre-A) (Fig. 2A,B) and not
after (Andersen et al. 2020). The virulence conferred by this dele-
tion to the coronaviruses constitutes the focus of several studies
(Lau et al. 2020).
In the last few months, the nucleotide change leading to the
amino-acid mutation D614G has also attracted the attention of
the scientific community, stimulated by the study of Korber et al.
(2020), among others and the media, claiming a fitness advantage
for this variant and an increased infectivity of the carrier coronavi-
rus; thismutation is generatedby the transversion changeA23403T,
which is one of the three diagnostic variants of haplogroup A2 (al-
though it shows lowmutational recurrence, appearing once within
haplogroup B). As shown in the present article, genetic drift andmi-
gration (likely favored by super-spreading transmission) has played
a fundamental role in the dispersion of SARS-CoV-2; therefore, it
seems there is no need to advocate natural selection or a
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transmission advantage for a particular strain to explain patterns of
variation of SARS-CoV-2 genomes worldwide. In support of this
claim, some countries with the highest impact of COVID-19 have
significantly lower frequencies of this mutation than other refer-
ence regions, for example, the frequency of A23403T is 77% in
Europe versus 54% in Spain and 42% in the United States. In addi-
tion, it was sub-branch A2a that succeeded in its dispersion world-
wide, not A2 where D614G first appeared. Therefore, our results
do not support claims of D614G being more advantageous in the
spread of SARS-CoV-2 around the world. Some reports have called
for caution in the interpretation of this mutation and other phylo-
genetic findings (Villabona-Arenas et al. 2020).
The origin of SARS-CoV-2 has become a very pressing ques-
tion. The results of the present study (TMRCA dating of SARS-
CoV-2, EBSP plot, and phylogeny) and the chronology of the ge-
nomes are compatible with an index case living in Wuhan-
China, most likely belonging to basal haplogroup A (but could
also belong to haplogroup B1 or B2), and existing not before the
beginning of November 2019. Subsequently, the coronavirus
was transmitted from a living animal (not necessarily bat) to a hu-
man host and then it started to spread from human to human. By
analyzing stored biological samples from cases occurring at the be-
ginning of the epidemic inWuhan, it would be possible to narrow
down the search for patient zero among those belonging to the
root. The phylogeny built in the present study would be compati-
ble with a single patient zero initiating the epidemic. Identifying
the index case would help better understand how and when the
spread of the pandemic began, a lesson that would be useful in fu-
ture pandemics. In agreement with previous studies (Andersen
et al. 2020), the theory of SARS-CoV-2 originating artificially in a
laboratory finds no support in the results of the present study, in
the sense that variation (within and between other species), and
the stepwise mutational evolution observed at SARS-CoV-2 ge-
nomes is as expected for a RNA virus in nature.
This study has several limitations (Supplemental Material)
and it warrants further expansion to clarify the role of super-
spreaders in COVID-19 by investigating epidemiological data lo-
cally. Detecting and analyzing the genome of super-spreaders
might shed light on the specific host genetic background (if any)
contributing to their increased propensity to transmit the patho-
gen, as well as to understand the mechanisms of infection and
transmission of the pathogen.Moreover, the phylogenic precision
to which we classified SARS-CoV-2 genomes will also serve disease
studies aimed at understanding the potential role of different path-
ogen strains in disease outcomes, and how these lineages correlate
to, and interact with, host genomic susceptibility. Analysis of var-
iation of SARS-CoV-2 genomes worldwide is fundamental for vac-
cine design (because there could be variants affecting antigenicity
and immunogenicity) (Kim et al. 2020), as well as for diagnostics
(Artesi et al. 2020). We have shown that a comprehensive phylo-
geographic analysis based on HQ SARS-CoV-2 genomes can pro-
vide useful information about the virus spread patterns and
dynamics, not only from a global perspective but also for events
that occur in particular geographic regions.
Methods
Database of SARS-CoV-2 sequences
We downloaded 4721 complete genomes from the GISAID data-
base (https://www.epicov.org/epi3/frontend) on April 6, 2020;
3392 of these 4721 sequences were noted as high quality (HQ;
>29 kbp, high cover only) based on the information provided by
GISAID on April 8, 2020. In order to minimize background noise
originating from potential sequencing errors, we carried out anal-
yses using the HQ SARS-CoV-2 genomes (for more information on
the features of the database, see Results, Supplemental Material,
and Supplemental Figure S14) unless stated otherwise. A higher
mutation rate is expected in indels and MNPs; therefore, unless
specified, this variation (together with all the ambiguities) was
eliminated from all the analyses to simplify phylogenetic recon-
structions and to allow visualization of main patterns of variation.
Although SARS-CoV-2 is an RNA virus, the data deposited in
GISAID are inDNA format.Metadata for these genomeswas down-
loaded from the Nextstrain repository (https://github.com/
nextstrain/ncov/tree/master/data) on April 7, 2020; this contains
information on geographic location of the sample (city, country,
and continental region) date of recruitment (submission date are
also available in GISAID but were not used in our analyses), age,
sex, and so forth. We also downloaded coronavirus genomes
from nine pangolins mainly sampled in the Guangdong province
(GISAID IDs [omitting prefix “EPI_ISL_“]): #410544, #410721,
#412860, #410539, #410538, #410543, #410542, #410541, and
#410540), three bats (#402131, #412977, and #412976) and the
reference SARS-CoV-1 genome (GenBank accession number:
NC_004718.3). In addition, we downloaded viral genomes ana-
lyzed from a tiger (GISAID: #420293) and a dog (GISAID:
#414518) presumably infected with SARS-CoV-2 by humans.
The SARS-CoV-2 genomes were aligned against the reference
sequence used by, for example, Nextstrain andmany investigators,
with GenBank accession number MN908947.3 (submitted on
January 5, 2020; GISAID ID #402125). This was the first SARS-
CoV-2 genome released on GenBank.
Alignment of SARS-CoV-2 genomes against the reference se-
quence was carried out using MUSCLE v3.8.31 software (Edgar
2004) and refined manually.
Apart from the discarded low-quality (LQ) sequences, we
trimmed the 5′ and 3′ untranslated regions to ensure comparabil-
ity among genomes, retaining a consensus sequence of 29,607 bp
that runs from position 169 to position 29776. In the text, we use
indistinctly the terms lineage, haplogroup, clade, cluster, and
strain.
Interspecific phylogenetic analysis
Webuiltmaximum likelihood (ML) trees to investigate interspecif-
ic phylogenetic relationships between SARS-CoV-2 genomes and
genomes analyzed from nine pangolins, three bats, and the refer-
ence SARS-CoV-1 genome (GenBank accession number:
NC_004718.3). Interspecific alignment was carried out using the
MAFFT program (Katoh et al. 2002) with default parameters.
Genetic distances (F84) were computed using dnadist and default
parameters, and the tree was built using dnapars; both programs
are included in the Phylip-3.697 software (Felsenstein 1989).
With the SARS-CoV-2 genes aligned for all genomes with nucleo-
tides in frame, and the ML trees, we used PAML 4 (Yang 2007) to
compute the statistics ω=Ka/Ks (also known as dN/dS), where Ka
is the number of nonsynonymous substitutions per nonsynony-
mous site, and Ks refers to synonymous substitutions per synony-
mous site. This ratio allows measuring the strength and mode of
natural selection acting on the protein genes (Supplemental
Table S6).
Intraspecific phylogeny of SARS-CoV-2
There have been several attempts at reconstructing the phylogeny
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phylogeny identifying the mutational changes characterizing
main clades and subclades. The interactive web-phylogeny pre-
sented by Nextstrain is probably the most elaborate attempt car-
ried out to date; this resource defines two main branches, A and
B, and nine sub-branches that cluster a variable number of se-
quences ranging from only three (haplogroup A7) or 52 sequences
(haplogroup A6) to 2279 (A2a) (April 28, 2020). GISAID identifies
three large clades according to changes located in the ORF8 gene
and other sequence variants: (1) Clade S: change L84S, with S refer-
ring to the SARS-CoV-2 spike S-glycoprotein located on the surface
of the viral envelope, and sequence variant T28144C; (2) Clade G:
change D614G and sequence variant A23404G; and (3) Clade V:
NSP3-G251V and sequence variant G26144T. In addition,
GISAID refers to the category “Other,”which is in reality paraphy-
letic. GISAID uses the reference sequence of a SARS-associated co-
ronavirus sequenced in 2003 (Marra et al. 2003). The GISAID tree
comes fromNextstrain; and the latter was built following a ML ap-
proach using IQ-TREE (Nguyen et al. 2015). Many of the earlier at-
tempts published in regular journals used a small number of
genomes, and the proposed nomenclature adds to the confusion;
for instance, Forster et al. (2020) also distinguished between A
and B, but in the opposite sense as in the original Nextstrain no-
menclature (and here).
We used different strategies to build the intraspecific phylog-
eny of SARS-CoV-2. First, a phylogeny based on ML was built to
find the phylogenetic root of all SARS-CoV-2 using the most
similar (higher identity) pangolin and bat coronavirus to the
SARS-CoV-2 genome as outgroups (GISAID IDs [omitting prefix
“EPI_ISL_“]): #410721 and #402131, respectively). In the particu-
lar case of SARS-CoV-2 and taking into account epidemiological
evidence, we know for sure that its root is among the initial ge-
nomes sequenced in China (most likely in the Hubei province).
First we used only genomes collected before February 29, 2020 (n
=621), and then genomes sampled only until mid-January (there-
by excluding B1 genomes) to reduce the noise inML trees generat-
ed by an unnecessarily large number of genomes that were
sampled and spread outside China.
In addition, we also constructed the ML phylogeny using the
whole genome database to find further support for the tree gener-
ated by maximum parsimony (see below).
We constructed all the ML trees with RAxML-HPC v.8
(Stamatakis 2014) and using rapid bootstrapping analysis with
1000 iterations. The best ML trees were visualized and edited
with FigTree v.1.4.4 (http://tree.bio.ed.ac.uk/software/figtree/).
Subsequently, the most parsimonious strategy allowed us to deter-
mine the main and secondary subclades of the SARS-CoV-2 tree,
identifying the characteristicmutationsof clades. Thisphylogenet-
ic procedure also allows us to count the occurrences of mutations
along branches, which serves as a goodproxy formutation-specific
stability (Weissensteiner et al. 2016).We followed the quality stan-
dards used to generate themost robustmolecular phylogeny based
onmaximum parsimony, namely, humanmtDNA (van Oven and
Kayser 2009). However, the novelty of SARS-CoV-2 genomes and
the use of a variety of high-throughput sequencing techniques
(Bandelt andSalas2012)prevents the filteringoutof sequencinger-
rors as efficiently as in other well-knownhaplotypic-based phylog-
enies (Salas et al. 2005). Thus, we built the parsimony tree by hand
using the following decision steps with regard to data filtering:
1. We used only genomes labeled as “high-coverage only” and
“complete” in GISAID.
2. We collapsed the sequences to the common sequence segment.
High-throughput sequencing procedures generate artifacts at
the 5′ and 3′ ends of the genome sequences, which generally
consist of deletions. Before eliminating the extremes of the se-
quences, we checked the complete genomes available to see if
there were any variants that could be phylogenetically
informative.
3. A solid phylogeny should be based on stable mutational vari-
ants; thus, only branches supported by at least five genomes
were considered.
4. Because many sub-haplogroups are supported by single muta-
tions, we only considered those having mutational stability
(here, equivalent to only a few occurrences along the most par-
simonious tree).
5. We used a nomenclature of clades that is as conservative as pos-
sible with Nextstrain but avoiding alteration of basic cladistic
rules (e.g., B1 cannot be ancestral of B).
We observed an excess of reversions at the tips of a fewphylogenet-
ic branches (e.g., C14805T reversion in a few A1a sequences). This
phylogenetic noise could be caused by the highmutational rate of
the mutations involved, recombination (which is not unusual be-
tween coronaviruses) (Rehman et al. 2020), or sequencing errors.
For this reason, we decided to not resolve these branches further
while we await new evidence based on higher sequence quality
genomes.
By simple counting of the mutational hits along the branch-
es and at the tips of the phylogeny, it is possible to infer the rel-
ative mutation stability of diagnostic sites. The mutations at the
tips of the phylogeny were counted only once within each termi-
nal branch. Supplemental Table S1 reports the number of occur-
rences in both the tree branches and in the tips of the phylogeny.
Recurrence of mutations along branches of the phylogeny is low,
which makes the tree very robust (Supplemental Material).
Phylogeny of super-spreader event
According to Colijn and Gardi (2014) “there are simple structural
properties of phylogenetic trees which, when combined, can dis-
tinguish communicable disease outbreaks with a super-spreader,
homogeneous transmission and chains of transmission.”
Further, Leventhal et al. (2012) state that “The level at which a
phylogenetic tree is able to resolve any contact structure depends
on the rate of evolution of the pathogen. In cases such as HIV,
where the rates of evolution are high enough to result in substan-
tial genetic differences between virus populations of individual
hosts, a phylogenetic tree may reveal contact structure down to
the individual level.” Because the SARS-CoV-2 has a compar-
able evolution rate as HIV (Lemey et al. 2006; Patiño-Galindo
and González-Candelas 2017; Zanini et al. 2017), we carried
out phylogenetic analysis aimed at distinguishing patterns
of transmission.
In particular, we are interested in computing phylogenetic
features of SARS-CoV-2 transmissions for our best candidates
(those haplotypes that experienced a high frequency locally
and in a short time period) and comparing them to those ob-
tained using the remaining haplotypes from the same specific re-
gion. We first built phylogenetic trees from sequence alignments
using SplitsTree5 (Huson and Bryant 2006). We used the R library
phylotop (https://cran.r-project.org/web/packages/phyloTop/) to
calculate the following tree features (Colijn and Gardy 2014):
• Cherry number/n: the number of cherries over number of leaves.
Cherries are pairs of genomes where one infected the other one
while any of them went on to infect anyone else. It is slightly
lower and more variable for super-spreader outbreaks.
• Colless’s I (index) or imbalance: It reaches higher values for su-
per-spreader outbreaks.
• IL number: portion of internal nodes with one leaf descendant.
It reaches higher values for super-spreader outbreaks.
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• Pitchforks: Like cherries, pitchforks decrease with increasing in-
fection rate (Metzig et al. 2019).
• Sacking index: the mean path length from tip to root. Slightly
higher in super-spreader outbreaks and lower in chain outbreaks.
• Staircase-ness: the portion of imbalance nodes (Norström et al.
2012). It shows much lower values for chain outbreaks.
These values were computed for the main super-spreader candi-
dates in specific geographic regions and also for the tree that in-
cludes the remaining haplotypes from the same region. The
comparison between values in both trees allows us to cross-com-
pare different transmission patterns from the same cultural/social
context.
In addition, we also carried out network analyses for the same
super-spreader candidate clades and also for a reported event of a
super-spreader host that occurred on the Diamond Princess cruise
ship for which we could access 25 SARS-CoV-2 genomes.
According to Sekizuka et al. (2020), the super-spreading event oc-
curring in the cruise ship may have originated from a single
COVID-19 patient who had disembarked in Hong Kong on
January 25, 2020.
To visualize the candidate super-spreader networks, we built
phylogenetic median joining networks using POPART software
(Leigh and Bryant 2015). The shape of the networks was double-
checked using other algorithms implemented in POPART; we
could not detect appreciable differences.
Statistical analysis
The average number of nucleotide differences per site between
DNA sequences or nucleotide diversity (π) (Nei and Li 1979), se-
quence/haplotype diversity (HD), and Tajima’s D statistics
(Tajima 1989) were computed for the main continental regions,
haplogroups, and gene partitions. Tajima’sD is a test for neutrality
in the context of infinite-sites model of sequence evolution, and it
is negligibly affected by S, sample size, and recombination
(Ramírez-Soriano et al. 2008).
Multidimensional scaling (MDS) was undertaken to identify
clusters of genetic variation by examining (1) all the variation ob-
served in the SARS-CoV-2 genomes, and (2) the phylogenetic diag-
nostic variants of the SARS-CoV-2 tree inferred from parsimony.
For this, we used the function cmdscale (library stats) from the stat-
istical software R Project for Statistical Computing v. 3.3.1 (https
://www.R-project.org/) (R Core Team 2019).
The geographic representation of haplogroup frequencies in
world maps was carried out using SAGA v. 7.6.2 (http://www
.saga-gis.org/) (Conrad et al. 2015) and the ordinary Krigingmeth-
od.Weused only regional data sets withmore than 10 genomes; to
avoid unnecessary loss of sampling points, a few of themwere col-
lapsed into nearest points to represent local areas, whenever possi-
ble, to reach the minimum sampling required.
From the sequence alignments and annotated files, we sum-
marized information on mutational patterns in the SARS-CoV-2
genomes (Supplemental Tables S7, S8; Supplemental Material).
We used a Fisher’s exact test to check if there were differences in
the transition-to-transversion ratio (ts/tv), and the synonymous/
nonsynonymous changes.
Supplemental Table S9 contains predicted pathogenicity val-
ues of the variants observed in the genomes analyzed in the pre-
sent study.
The ML tree and sampling dates were used for estimating the
TMRCA and molecular rates, fitting a molecular clock to the phy-
logeny through a fast relaxed-clock method based on a Gamma-
Poissonmixture model of substitution rates, and using the R pack-
age treedater (Volz and Frost 2017). We used the relaxed clock
because it offered a better fit to the data; it also identified and
removed tip outlier lineages to obtain a tree that better suited
the molecular clock. We estimated confidence intervals for rates
and dates using a parametric bootstrap approach.
The demography of SARS-CoV-2 sequences was inferred us-
ing the extended Bayesian skyline plot method (EBSP) (Heled
and Drummond 2008) implemented in BEAST v2.6.2
(Drummond and Rambaut 2007). EBSPs allow the inference of ef-
fective population size (Ne) through time and also estimate the
number of demographic changes from the data. We used a strict
clock and a rate of evolution of 0.80×10−3 [0.14×10−3 to 1.31×
10−3] s/s/y based on recent estimations (https://virological.org/t/
phylodynamic-analysis-176-genomes-6-mar-2020/356). Two in-
dependent Markov chain Monte Carlo (MCMC) runs of
200,000,000 steps each were performed, with samples taken every
1000 steps and 10% discarded as burn-in. Following Tracer (v. 1.6)
output (http://tree.bio.ed.ac.uk/software/tracer/) (Drummond
and Rambaut 2007) inspection for distributions convergence,
both runs were combined independently using LogCombiner
v1.8.2 (Drummond and Rambaut 2007), with 10% discarded as
burn-in. EBSP data was plotted using R software (R Core Team
2019).
The metadata in GISAID contains information on the sex
and age of the COVID-19 patients. These data, in combination
with the phylogeny, allow investigating for possible association
among haplogroups, sex, and age. Association tests were carried
out for the main (sub)haplogroups (A, B, A1a, A2a, A3, A3a, A4a,
A9b, B1a, B3a; all with sample size >50). We carried out a Mann–
Whitney U test to analyze haplogroup association with age.
Because each region has its own haplogroup frequency patterns
and epidemiological characteristics, we considered a nonparamet-
ric Kruskal–Wallis test using all the sampling data per regions and
main haplogroups. Association between haplogroups/regions and
sex was explored using the Fisher’s exact test. The nominal signifi-
cance value was set to 0.05. Bonferroni adjustment was used to ac-
count for multiple testing.
In-house R and Nim (http://nim-lang.org) scripts (uploaded
to https://gitlab.com/xbello/gr_2020) (Supplemental Code) were
used to display results obtained from the different software packag-
es used.
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